Omeros Corporation Depreciation & Amortization 2011-2026 | OMER

Annual Depreciation & Amortization Omeros Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
964 K	950 K	920 K	952 K	1.39 M	1.62 M	1.79 M	962 K	551 K	300 K	209 K	317 K	302 K	320 K	435 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.79 M	209 K	798 K

Quarterly Depreciation & Amortization Omeros Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
200 K	200 K	289 K	-	200 K	200 K	204 K	-	200 K	300 K	186 K	-	300 K	200 K	278 K	-	300 K	400 K	390 K	-	400 K	400 K	402 K	-	400 K	827 K	377 K	-	654 K	429 K	223 K	-	378 K	234 K	115 K	-	211 K	122 K	53 K	-	161 K	107 K	55 K	-	246 K	164 K	82 K	-	222 K	145 K	67 K	-	232 K	165 K	93 K	-	336 K	227 K	168 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
827 K	53 K	256 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.63	-1.22 %	$ 16.5 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.41	-3.67 %	$ 230 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 316.2	-4.28 %	$ 41.4 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.89	-	$ 4.85 M	China
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Cerus Corporation CERS	1.43 M	$ 1.8	-2.7 %	$ 343 M	USA
AbbVie ABBV	762 M	$ 202.28	-2.11 %	$ 358 B	USA
Aquestive Therapeutics AQST	548 K	$ 4.04	-1.28 %	$ 432 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.63	-2.69 %	$ 191 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.32	-2.06 %	$ 992 M	Canada
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 8.12	-1.22 %	$ 222 M	Israel
Ardelyx ARDX	3.06 M	$ 5.8	-2.93 %	$ 1.4 B	USA